About Emergent BioSolutionsEmergent BioSolutions is a global specialty biopharmaceutical company dedicated to one simple mission—to protect and enhance life. We develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us @emergentbiosolu.
Investor Contact:Robert G. BurrowsVice President, Investor Relations240firstname.lastname@example.orgMedia Contact:Tracey Schmitt LintottSenior Vice President, Global Public Affairs240-631-3281SchmittT@ebsi.com